FDA
Lamivudine, Zidovudine Tabs 150MG/300MG Co-Packaged with Nevirapine Tabs 200MG
Composition
- Active ingredients
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG; NEVIRAPINE 200MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022356.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lamivudine, Zidovudine Tabs 150MG/300MG Co-Packaged with Nevirapine Tabs 200MG
- Active substance
- lamivudine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Hetero Drugs LTD
- Status
- Tentative approval
- FDA approval
- 7 May 2009
- Application
- NDA022356-001